Catalyst

Slingshot members are tracking this event:

Ritter Pharmaceuticals (RTTR) Completes Last Monitoring Visit in Phase 2b/3 Clinical Trial Evaluating RP-G28 in Lactose Intolerance

Source Link:
http://www.ritterpharmaceuticals.com/ritter-pharmaceuticals-concludes-last-patient-visit-of-its-phase-2b3-clinical-trial-of-rp-g28-for-the-treatment-of-lactose-intolerance

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
RTTR
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Oct 18, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Last Monitoring Visit, Phase 2b/3, Rp-g28, Lactose Intolerance
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.